Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease
暂无分享,去创建一个
C. Larsson | A. Stenman | K. Jatta | J. Zedenius | I. Shabo | Johan O Paulsson | C. Juhlin | Martin Hysek | A. Höög | Adam Stenman
[1] C. Juhlin. A Clinical Overview of Telomerase-Associated Aberrancies in Follicular Thyroid Tumors as Diagnostic and Prognostic Markers: Tert Alert! , 2020, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.
[2] Xiao-Ding Liu,et al. Mutation profiles of follicular thyroid tumors by targeted sequencing , 2019, Diagnostic Pathology.
[3] A. Dobrovic,et al. TERT gene: its function and dysregulation in cancer , 2019, Journal of Clinical Pathology.
[4] F. Borson‐Chazot,et al. TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma. , 2019, European journal of cancer.
[5] I. Shabo,et al. Clear Cell Variant of a Follicular Thyroid Tumor With Uncertain Malignant Potential: A Case Report , 2018, International journal of surgical pathology.
[6] R. Parenti,et al. MiR-19a Overexpression in FTC-133 Cell Line Induces a More De-Differentiated and Aggressive Phenotype , 2018, International journal of molecular sciences.
[7] Simion I. Chiosea,et al. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology , 2018, JAMA oncology.
[8] C. Larsson,et al. TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours. , 2018, Endocrine-related cancer.
[9] Yan Wang,et al. The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer , 2018, Medicine.
[10] C. Larsson,et al. Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology , 2018, The Journal of clinical endocrinology and metabolism.
[11] K. Jatta,et al. TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours—three examples from the clinical routine , 2018, Virchows Archiv.
[12] Koichi Ito,et al. Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation , 2017, Modern Pathology.
[13] Tomasz Stokowy,et al. Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours , 2017, International journal of molecular sciences.
[14] W. Faquin,et al. Metastatic Follicular Thyroid Carcinoma and the Primary Thyroid Gross Examination: Institutional Review of Cases from 1990 to 2015 , 2017, Endocrine Pathology.
[15] M. Molloy,et al. Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy , 2016, Scientific Reports.
[16] V. Tergaonkar,et al. Reactivation of telomerase in cancer , 2016, Cellular and Molecular Life Sciences.
[17] C. Larsson,et al. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas , 2014, Oncogene.
[18] M. Xing,et al. Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy. , 2014, Endocrine-related cancer.
[19] C. Larsson,et al. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA , 2014, Cancer.
[20] M. Xing,et al. TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer. , 2014, The Journal of clinical endocrinology and metabolism.
[21] R. Celestino,et al. TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas , 2014, The Journal of clinical endocrinology and metabolism.
[22] J. Bishop,et al. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. , 2013, Endocrine-related cancer.
[23] Jean-Fred Fontaine,et al. DNA microarray and miRNA analyses reinforce the classification of follicular thyroid tumors. , 2013, The Journal of clinical endocrinology and metabolism.
[24] D. Schadendorf,et al. TERT Promoter Mutations in Familial and Sporadic Melanoma , 2013, Science.
[25] Lynda Chin,et al. Highly Recurrent TERT Promoter Mutations in Human Melanoma , 2013, Science.
[26] H. Moch,et al. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas. , 2013, The Journal of clinical endocrinology and metabolism.
[27] A. Rajwanshi,et al. Interobserver variability amongst cytopathologists and histopathologists in the diagnosis of neoplastic follicular patterned lesions of thyroid , 2011, Diagnostic Cytopathology.